scorecardresearch
Saturday, November 2, 2024
TopicJohnson and Johnson

Topic: Johnson and Johnson

Two doses of J&J’s vaccine slashes Omicron hospital stays in South Africa by up to 85%

The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.

Johnson & Johnson vaccine doesn’t provide antibody protection against Omicron, lab study finds

The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.

US scientists suggest link between J&J vaccine and brain blood clots, but warn against panic

Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

US FDA clears Moderna, J&J booster shots, allows ‘mix and match’ of Covid vaccines

The Centers for Disease Control & Prevention will consult an expert panel later this week before finalising official recommendations for who should get boosters and when.

Johnson & Johnson seeks nod to conduct vaccine trails for 12-17 age group in India

Earlier in August, the US pharma giant Johnson & Johnson was given emergency use approval in India for its single-dose Covid-19 vaccine.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

Johnson & Johnson’s Covid vaccine gets emergency use approval in India

With the approval of the single-dose J&J vaccine, India has five vaccines that have got approval for emergency use. The others are Covishield, Covaxin, Sputnik V and Moderna.

Johnson & Johnson applies for Emergency Use Authorization of its Covid vaccine in India

Johnson & Johnson Friday said that it remains committed to bringing the single-dose vaccine and accelerating its availability in India through collaboration with Biological E.

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

All about Major Bob Khathing, whose daring expedition & diplomatic parleys secured Tawang for India

The decorated Naga officer from Manipur also served as envoy to Myanmar & Nagaland chief secy. Defence Minister Rajnath Singh inaugurated a museum dedicated to the Tawang hero Thursday.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.